Ty Gluckman, MD: Using Telemedicine to Improve Access to Care

May 6, 2022
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

The pandemic has removed some of the barriers of medicine.

Access to doctors has long been one of the biggest hurdles in medicine.

For example, someone living in New York City has inherent advantages in accessing top doctors over someone who may live in a more rural part of the country.

However, with the advent of telemedicine during the COVID-19 pandemic, some of these barriers that have long existed may be finally coming to a close.

In an interview with HCPLive® during Pri-Med West 2022 in Anaheim, Ty Gluckman, MD, Medical Director of the Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), said telemedicine has improved care for many, but there still remains some challenges.

For example, regulations make crossing state lines difficult for many.

In addition, not every disease can be treated over a video conferring call.

Gluckman said he is able to consult with patients about things like cholesterol, but there are some cardiovascular diseases that will still require in-person appointments, like patients with heart failure.

But overall, the advent of telehealth is a net positive.

“I would say the pandemic and telehealth has dramatically accelerated the ability to overcome some challenges of access,” he said.